Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study
about
Auditory verbal hallucinations and continuum models of psychosis: A systematic review of the healthy voice-hearer literatureNeuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia.Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission.Pathway-Specific Dopamine Abnormalities in Schizophrenia.The 4th Schizophrenia International Research Society Conference, 5-9 April 2014, Florence, Italy: a summary of topics and trends.Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia.Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging studyIncreased Nigral SLC6A3 Activity in Schizophrenia Patients: Findings From the Toronto-McLean CohortsGlutamate and dopamine in schizophrenia: an update for the 21st centuryNeurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and its reversal by dopaminergic antagonism.Unexpected global impact of VTA dopamine neuron activation as measured by opto-fMRI.The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review.Presynaptic dopaminergic function: implications for understanding treatment response in psychosis.Role of presynaptic phosphoprotein synapsin II in schizophrenia.Striatal and Extrastriatal Dopamine Transporter Availability in Schizophrenia and Its Clinical Correlates: A Voxel-Based and High-Resolution PET Study.The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.Protein Markers of Neurotransmitter Synthesis and Release in Postmortem Schizophrenia Substantia Nigra.Joint sparse canonical correlation analysis for detecting differential imaging genetics modules.Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain.New Targets for Schizophrenia Treatment beyond the Dopamine HypothesisDevelopment of a highly sensitive immunohistochemical method to detect neurochemical molecules in formalin-fixed and paraffin-embedded tissues from autopsied human brains.Dopamine and the aberrant salience hypothesis of schizophrenia.Psychosis in Spinocerebellar Ataxias: a Case Series and Study of Tyrosine Hydroxylase in Substantia Nigra.Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience.Substantia nigra ultrastructural pathology in schizophrenia.Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve Schizophrenia.Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study.Tyrosine hydroxylase localization in the nucleus accumbens in schizophrenia.A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia.Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis.SchizophreniaThe relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study
P2860
Q28066014-9A312FB9-CBA7-4040-8FBE-40BAFE5CF4D5Q34028030-434BE62C-9089-4B58-89C3-6A90F71F2F41Q34410670-1B24AC0D-A7A7-4047-BC01-8D137ECA6EBAQ34527656-CED77340-95C2-45DA-AA78-0442ECD3E1FEQ35382798-79B91C5A-7753-4051-BEFE-EC4262525715Q35858750-72875E16-3BF5-4078-BFD9-F11DAA12B5FFQ36623197-07D581D7-2AED-4E5B-B8C3-016648D03991Q36817270-04056134-F219-4F46-9280-87A5AA576DD6Q36992322-7586FF47-1CE6-4E17-8797-9CBAB76CE930Q37009643-0786D954-004A-474D-8AE4-A638944319C4Q37609217-3191DC20-503B-4ABA-BB1F-76C2D2739176Q37633236-1788C13B-0FFB-418F-A888-2F6EBBC7DF1FQ38219577-CA8EAB41-5C6C-4374-9E77-19E0FED746DEQ38596474-9854FACE-AB88-4A2D-9E92-27C7F13E3C47Q38972564-B298D423-4A1C-40AB-B0C1-DF2DA216DC21Q38976291-CEAA7C9E-F137-423B-8E43-07641710F005Q39464596-4718C100-F849-4917-8A34-C2D789A2F9A2Q39551604-C6F75F39-6969-4BBE-8715-736C8655D731Q41271272-C4E85E87-35D4-4D28-9063-A0F10FE13396Q41573540-5D89841E-FB8E-4713-B376-FD7B2A7543FEQ42019401-C83399C1-8623-40BC-A505-2183897FF4E9Q42544638-EAB05A46-9AE7-4697-89AC-4C9D07EFA407Q45304094-633AF488-FA79-41C9-AEE9-DE900D277F8CQ47550545-0090EFF9-8A1C-4B26-A648-B43C5119B13EQ47561103-F3D177C1-05DB-4DE7-B9D7-CA42BAE6EA15Q47596297-033B18DD-C6B5-4105-8203-66B918E2BE72Q47959577-8B105484-E42E-495E-8F27-4AB36297E004Q48219402-8F3E1C4B-B2DE-4F52-BD45-811118F96201Q49032517-550AB4DD-25B4-4CED-A4FA-11D71C56B6B8Q50096180-D1FB2736-4970-4F80-9FC7-CFB00C029987Q50192659-D7C2C6FC-A0E5-466C-89C7-916B3A441188Q56959104-E3535B61-CF3B-4A36-A728-AF3FC2BC9EF4Q58793943-ABA82628-C53D-48E2-8AD3-0D0C1E5002A0
P2860
Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Midbrain dopamine function in ...... sion tomographic imaging study
@en
Midbrain dopamine function in ...... ion tomographic imaging study.
@nl
type
label
Midbrain dopamine function in ...... sion tomographic imaging study
@en
Midbrain dopamine function in ...... ion tomographic imaging study.
@nl
prefLabel
Midbrain dopamine function in ...... sion tomographic imaging study
@en
Midbrain dopamine function in ...... ion tomographic imaging study.
@nl
P2093
P2860
P50
P356
P1433
P1476
Midbrain dopamine function in ...... sion tomographic imaging study
@en
P2093
Alice Egerton
Garret Leung
Kemal Ibrahim
Matthew Williams
P2860
P304
P356
10.1093/BRAIN/AWT264
P407
P577
2013-10-03T00:00:00Z